PMID- 16796384 OWN - NLM STAT- MEDLINE DCOM- 20060811 LR - 20190516 IS - 1550-7416 (Electronic) IS - 1550-7416 (Linking) VI - 8 IP - 2 DP - 2006 May 12 TI - Causes and consequences of methamphetamine and MDMA toxicity. PG - E337-47 AB - Methamphetamine (METH) and its derivative 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) are 2 substituted amphetamines with very high abuse liability in the United States. These amphetamine-like stimulants have been associated with loss of multiple markers for dopaminergic and serotonergic terminals in the brain. Among other causes, oxidative stress, excitotoxicity and mitochondrial dysfunction appear to play a major role in the neurotoxicity produced by the substituted amphetamines. The present review will focus on these events and how they interact and converge to produce the monoaminergic depletions that are typically observed after METH or MDMA administration. In addition, more recently identified consequences of METH or MDMA-induced oxidative stress, excitotoxicity, and mitochondrial dysfunction are described in relation to the classical markers of METH-induced damage to dopamine terminals. FAU - Quinton, Maria S AU - Quinton MS AD - Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Room L -613, 715 Albany Street, Boston, MA 02118, USA. FAU - Yamamoto, Bryan K AU - Yamamoto BK LA - eng PT - Journal Article PT - Review DEP - 20060512 PL - United States TA - AAPS J JT - The AAPS journal JID - 101223209 RN - 0 (Neurotoxins) RN - 44RAL3456C (Methamphetamine) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) RN - VTD58H1Z2X (Dopamine) SB - IM MH - Blood-Brain Barrier MH - Dopamine/physiology MH - Humans MH - Methamphetamine/*toxicity MH - Mitochondria/drug effects/pathology/physiology MH - N-Methyl-3,4-methylenedioxyamphetamine/*toxicity MH - Neurotoxins/*toxicity MH - Oxidative Stress/drug effects MH - Substance-Related Disorders/*epidemiology MH - United States/epidemiology PMC - PMC3231568 EDAT- 2006/06/27 09:00 MHDA- 2006/08/12 09:00 PMCR- 2007/05/12 CRDT- 2006/06/27 09:00 PHST- 2006/06/27 09:00 [pubmed] PHST- 2006/08/12 09:00 [medline] PHST- 2006/06/27 09:00 [entrez] PHST- 2007/05/12 00:00 [pmc-release] AID - BF02854904 [pii] AID - 10.1007/BF02854904 [doi] PST - epublish SO - AAPS J. 2006 May 12;8(2):E337-47. doi: 10.1007/BF02854904.